[Renal tubular protection of shenqi fuzheng injection in treating primary nephrotic syndrome].
To explore the effect and mechanism of Shenqi Fuzheng injection (SFI) on renal tubule in treating patients with primary nephrotic syndrome (PNS). Eighty patients with PNS were randomly divided into two groups, 40 patients in the control group were treated by conventional therapy mainly with glucocorticoids; 40 patients in the treated group treated by conventional therapy plus intravenous injection of SFI additionally. The changes of serum albumin (sALB), urinary protein in 24 hrs (UP/24h), urinary levels of retinal binding protein (RBP), beta2 microglobulin (beta2-MG) and N-acetyl-D-glucosaminidase (NAG) as well as blood lipids before and after treatment were observed. After treatment, level of sALB increased and urinay levels of RBP, beta2-MG, NAG, UP/24h decreased in the treated group, as compared with those in the control group, showing significant difference (P < 0.05 or P < 0.01). Blood lipids level abated significantly after treatment in both groups (P < 0.01), comparison between them, levels of TC and LDL-C in the treated group were significantly lower than those in the control group (P < 0.01). SFI has protective effect on renal tubule in patients with PNS, also has effect on lowering blood lipids.